One device. Countless pathogens.
PCR-level accuracy at near-serology costs - Built for frontline health professionals.
9.3M
Tick bites / year
450K
Lyme cases / year
43%
EU pop. at risk
The Challenge
Treating an infectious disease begins with identifying it, testing for it. Yet today's diagnostic infrastructure is expensive, centralized, short of technicians, and experiencing supply issues.
The system is simultaneously over-complicated and under-deployed, leaving vast numbers of infections undetected each year.
Gallisa addresses this structural failure by empowering frontline healthcare professionals (Pharmacists, GPs, and Emergency Responders) with their own PCR-accurate platform to test on the spot and deliver results that physicians can act on immediately.
Segmentation by test and disease type creates complexity thus high investment and maintenance costs for providers. These are transmitted to the Patients.
Expensive equipment and the shortage of highly trained specialists lead to uneven access to diagnostics across countries and regions.
Testing bottlenecks and prohibitive costs lead to systematic under-reporting, leaving patients untreated and public agencies blind to the reality of the ground.
Cost reduction vs PCR
up to 80%
Our Solution
Gallisa redefines point-of-care diagnostics through an integrated hardware platform and automated workflows that bring
testing directly to frontline healthcare professionals.
General practitioners, Pharmacists, and Emergency responders gain the
ability to perform reliable diagnostics at the point of care, accelerating diagnosis and enabling evidence-based clinical decision-making without delay.
Single device with interchangeable single use chemical assays replacing multiple specialised instruments.
With its three step process, the platform delivers clinical-grade precision result at near-serology costs.
Standardised and automated workflows eliminating dependence on highly trained personnel and minimising human error.
Testing Pathway
From sample collection to diagnosis in four steps — no formal laboratory training required.
Thanks to the high level of automation provided by Gallisa's Testing platform and companion Web-App , healthcare professional and patients can run their tests with ease.
The patient or if need be, the healthcare professional collects a sample using the material available in the test kit.
The patient places his sample along with the test kit inside of the test platform.
The platform processes the given sample automatically in 30 mins and provides the patient with a readout.
Thanks to the companion Web-App, the patient receives a medical report to share with their physician.
Our Advantage
A fundamental shift toward integrated, adaptable diagnostic systems deployed in the hands of Pharmacists, General Practitioners and Emergency Responders.
The Team
A multidisciplinary duo committed to transforming infectious disease diagnostics from the ground up.
Co-Founder & CEO
Trained at the intersection of engineering at EPFL and business strategy at HEC Paris, with substantial experience in the pharmaceutical industry gained at the hands of giants such as GSK, Lonza, and Merck Group.
LinkedInCo-Founder & CTO
Trained in life science and IVD development at EPFL, with hands-on experience leading the end-to-end development of diagnostic assays in fast-paced start-up environments.
LinkedInContact Us
Whether you're a healthcare professional, an investor, or simply curious, pick the channel that fits you best.